`
`David L. Cavanaugh
`Reg. No. 36,476
`Heather M. Petruzzi
`Reg. No. 71,270
`Owen K. Allen
`Reg. No. 71,118
`Robert J. Gunther, Jr.
`Pro Hac Vice To Be Filed
`WilmerHale
`1875 Pennsylvania Ave., NW
`Washington, DC 20006
`
`
`Adam R. Brausa
`Reg. No. 60,287
`Daralyn J. Durie
`Pro Hac Vice To Be Filed
`Durie Tangri LLP
`217 Leidesdorff Street
`San Francisco, CA 94111
`
`
`Jeffrey P. Kushan
`Reg. No. 43,401
`Sidley Austin LLP
`1501 K Street, N.W.
`Washington, D.C.
`20005
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`GENENTECH, INC. AND CITY OF HOPE,
`Patent Owners.
`____________________________________________
`
`Case IPR2016-00710
`U.S. Patent 6,331,415
`____________________________________________
`
`PATENT OWNERS’ UPDATED MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`IPR2016-00710
`Patent Owners’ Updated Mandatory Notices
`
`PATENT OWNERS’ UPDATED MANDATORY NOTICES
`
`Patent Owners Genentech, Inc. and City of Hope hereby file updated
`
`mandatory notices pursuant to 37 C.F.R. § 42.8(b)(1).
`
`I.
`
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), Patent Owners identify the following
`
`updates to matters that relate or may relate to U.S. Patent Application No.
`
`07/205,419, which issued as U.S. Patent No. 6,331,415 (“the ʼ415 patent”):
`
`• U.S. Patent No. 7,923,221, which claims the benefit of the priority
`
`date of U.S. Patent No. 6,331,415, was the patent-in-suit in Sanofi-
`
`Aventis U.S. LLC v. Genentech, Inc., Case No. 2:15-cv-05685 GW
`
`(C.D. Cal. July 27, 2015), which is now closed;
`
`• U.S. Patent No. 7,923,221, which claims the benefit of the priority
`
`date of U.S. Patent No. 6,331,415, was the patent-in-suit in Genzyme
`
`Corporation v. Genentech, Inc. and City of Hope, Case No. 2:15-cv-
`
`09991 (C.D. Cal. December 30, 2015), which is now closed;
`
`• U.S. Patent No. 7,923,221, which claims the benefit of the priority
`
`date of U.S. Patent No. 6,331,415, is the patent-in-suit in Merck Sharp
`
`& Dohme Corp. v. Genentech, Inc. and City of Hope, Case No. 2:16-
`
`cv-4992 (C.D. Cal. July 7, 2016), which is pending;
`
`- 2 -
`
`
`
`
`
`IPR2016-00710
`Patent Owners’ Updated Mandatory Notices
`
`• U.S. Patent No. 6,331,415 was the patent at issue in Sanofi-Aventis
`
`U.S. LLC and Regeneron Pharmaceuticals, Inc. v. Genentech, Inc.
`
`and City of Hope, IPR2015-01624, to which IPR2016-00460 was
`
`joined, and which is now terminated;
`
`• U.S. Patent No. 6,331,415 was the patent at issue in Genzyme
`
`Corporation v. Genentech, Inc. and City of Hope, IPR2016-00383,
`
`which was not instituted;
`
`• U.S. Patent No. 6,331,415 was the patent at issue in Genzyme
`
`Corporation v. Genentech, Inc. and City of Hope, IPR2016-00460,
`
`which was joined to IPR2015-01624 (which is now terminated);
`
`• U.S. Patent No. 6,331,415 is the patent at issue in Merck Sharp &
`
`Dohme Corp. v. Genentech, Inc. and City of Hope, IPR2016-01373,
`
`which is pending.
`
`Patent Owners do not concede that any of the above-identified proceedings
`
`involving patents other than the ʼ415 patent would affect, or be affected by, a
`
`decision in the present IPR.
`
`II. COUNSEL
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), Patent Owners identify the following
`
`updated counsel information.
`
`- 3 -
`
`
`
`
`Lead Counsel:
`
`IPR2016-00710
`Patent Owners’ Updated Mandatory Notices
`
`David L. Cavanaugh, Reg. No. 36,476
`
`
`Back-up Counsel:
`
`
`Robert J. Gunther, Jr., Pro Hac Vice motion to be submitted
`
`Heather M. Petruzzi, Reg. No. 71,270
`
`Owen K. Allen, Reg. No. 71,118
`
`Adam R. Brausa, Reg. No. 60,287
`
`Daralyn J. Durie, Pro Hac Vice motion to be submitted
`
`Jeffrey P. Kushan, Reg. No. 43,401
`III. SERVICE INFORMATION
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), Patent Owners identify the following
`
`updated service information.
`
`Electronic mail address:
`
`David.Cavanaugh@wilmerhale.com
`
`Heather.Petruzzi@wilmerhale.com
`
`Owen.Allen@wilmerhale.com
`
`Robert.Gunther@wilmerhale.com
`
`abrausa@durietangri.com
`
`ddurie@durietangri.com
`
`jkushan@sidley.com
`
`
`- 4 -
`
`
`
`IPR2016-00710
`Patent Owners’ Updated Mandatory Notices
`
`
`Electronic service on lead and back up counsel is approved and preferred.
`
`
`Postal Mail, Courier or Hand Delivery:
`Wilmer Cutler Pickering Hale and Dorr LLP
`1875 Pennsylvania Avenue NW
`Washington, DC 20006
`David.Cavanaugh@wilmerhale.com
`Telephone: 202-663-6025
`Facsimile: 202-663-6363
`
`Date: September 14, 2016
`
`
`
`Respectfully submitted,
`
`By: /David L. Cavanaugh/
`David L. Cavanaugh
`Reg. No. 36,476
`Wilmer Cutler Pickering Hale and Dorr LLP
`1875 Pennsylvania Avenue NW
`Washington, DC 20006
`
`- 5 -
`
`
`
`IPR2016-00710
`Patent Owners’ Updated Mandatory Notices
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that, on September 14, 2016, I caused a true and correct
`copy of the foregoing materials:
`
`
`• Patent Owners’ Updated Mandatory Notices Under 37 C.F.R.
`§42.8
`
`to be served via electronic mail on the following attorneys of record:
`
`Deanne M. Mazzochi
`Paul J. Molino
`William A. Rakoczy
`Eric Hunt
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`dmazzochi@rmmslegal.com
`paul@rmmslegal.com
`wrakoczy@rmmslegal.com
`ehunt@rmmslegal.com
`Mylan_IPR_Service@rmmslegal.com
`
`
`
`/Owen K. Allen/
`Owen K. Allen
`Reg. No. 71,118
`Wilmer Cutler Pickering Hale and Dorr LLP
`950 Page Mill Road
`Palo Alto, CA 94304
`(650)600-5029
`
`- i -